June 13, 2018 In News By Laia Tremosa

First photoactive drug to fight Parkinson’s disease

[caption id="attachment_5144" align="alignleft" width="260"] The MRS7145 photoactive drug is effective in animal models with Parkinson’s disease, according to the study published in the Journal of Controlled Release[/caption]   An international team has designed the first potentially therapeutic photoactive drug –MRS7145– to fight Parkinson’s disease, according to the...

0
November 17, 2017 In News By UCCi Divulgacio

“Collaboration between different areas is very important to be competitive and produce new knowledge”

[caption id="attachment_4470" align="alignleft" width="300"] Per Svenningson, professor from Karolinska Instituet (Sweden).[/caption] The Eurolife Autumn Symposium took place on the 24th and 25th of October, and was organized by the University of Barcelona, the Institute of Neurosciences of the UB and the master’s degree in Neurosciences. Researcher Per...

0
March 7, 2017 In News By UCCi Divulgacio

New therapeutic target that could slow Parkinson’s progression

A team of researchers of the Institute of Neurosciences of the University of Barcelona and the Institute for Bioengineering of Catalonia (IBEC) have identified a possible mechanism to slow the neurodegenerative progression of Parkinson’s disease. Parkinson’s neuronal degeneration is caused by Lewy bodies, abnormal aggregates created...

0